MedTrace Logo

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

NCT00214630 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 825

Last updated 2010-11-19

No results posted yet for this study

Summary

Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes

Conditions

  • Acute Coronary Syndromes

Interventions

DRUG

rosuvastatin calcium

DRUG

atorvastatin

Sponsors & Collaborators

Principal Investigators

  • AstraZeneca Crestor Medical Science Director, MD · AstraZeneca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States
  • Costa Rica
  • El Salvador
  • Morocco
  • Panama

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00214630 on ClinicalTrials.gov